Enzymatic vitreolysis with recombinant tissue plasminogen activator for vitreomacular traction
Dorota Raczyńska,1 Paweł Lipowski,1 Katarzyna Zorena,2 Andrzej Skorek,3 Paulina Glasner1 1Department of Ophthalmology, Medical University of Gdańsk, Poland; 2Department of Immunobiology and Environment Microbiology, Medical University of Gdańsk, Poland; 3Department of Otolaryngology, Medical Univer...
Main Authors: | Raczyńska D, Lipowski P, Zorena K, Skorek A, Glasner P |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-11-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | https://www.dovepress.com/enzymatic-vitreolysis-with-recombinant-tissue-plasminogen-activator-fo-peer-reviewed-article-DDDT |
Similar Items
-
Pneumatic Vitreolysis for the Treatment of Vitreomacular Traction Syndrome
by: Hüseyin Baran Özdemir, et al.
Published: (2019-08-01) -
Pneumatic vitreolysis for management of symptomatic focal vitreomacular traction
by: Clement K Chan, et al.
Published: (2017-01-01) -
Effect of pneumatic vitreolysis in management of patients with symptomatic focal vitreomacular traction
by: Ahmed N. Fouad, et al.
Published: (2022-03-01) -
Evaluating the effect of Perfluoropropane assisted pneumatic vitreolysis in cases of symptomatic focal vitreomacular traction
by: Osama R Elnaggar, et al.
Published: (2023-01-01) -
Enzymatic vitreolysis for the treatment of tractional diabetic macular edema
by: Bernardete Pessoa, et al.
Published: (2019-08-01)